Glucagon Structure: In-Depth Analysis of Peptide Product Composition
Title: Glucagon Structure: In-Depth Analysis of Peptide Product Composition Abstract: Glucagon, a 29-amino-acid peptide, exhibits a critical α-helical structure essential for its glucose-elevating bioactivity. Current market trends show a 12.3% CAGR in therapeutic peptides, driven by diabetes and metabolic disorder applications. Leading brands prioritize purity (>98% by HPLC) and endotoxin levels (<1 EU/mg), with lyophilized powder offering superior stability over liquid formulations. Regulatory compliance (GMP, USP <797>) is mandatory for clinical use. Selection criteria emphasize sequence integrity, salt form (acetate vs. TFA), and cold-chain logistics (-20°C). Industry data indicates 78% of failures stem from aggregation during transport, underscoring the need for validated packaging.